Tag: Life Science | Page 78 | NAI 500 | Page 78

- English
  - 简体中文
  - 繁體中文

Home
Life Science

Filter

Cipla

Cipla Forms $30 Million China Respiratory Drug JV with Jiangsu Acebright

Jul 17, 2019

The Yield Growth(Private)

YIELD GROWTH Announces Distribution Agreement with Parcelpal

Jul 17, 2019

Alphamab Oncology

Suzhou’s Alphamab Oncology Approved to IPO on Hong Kong Exchange

Jul 16, 2019

Ascentage

Ascentage Starts China Trial of Apoptosis Cancer Drug

Jul 16, 2019

HitGen

HitGen Approved for $97 Million IPO on Shanghai’s STAR Board

Jul 16, 2019

I-Mab

I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China

Jul 16, 2019

Harbour

Harbour Antibodies Partners with Abveris, a Boston Drug Discovery CRO

Jul 16, 2019

GTEC Holdings Ltd (TSXV:GTEC)

GTEC Announces Voting Results of Annual and Special Meeting of Shareholders

Jul 15, 2019

Miaoshou Doctor

Miaoshou Doctor Completes $73 Million C+ Round at $1 Billion Valuation

Jul 13, 2019

Novartis

Novartis Plans to File 50 NDAs in China over the Next Five Years

Jul 13, 2019

Johnson & Johnson

Johnson & Johnson to test HIV vaccine in US and Europe

Jul 13, 2019

Rwanda

Collaboration with US med schools helps Rwanda improve women’s health care

Jul 13, 2019

WELL Health Technologies Corp (TSXV:WELL)

WELL Health Announces Grant of RSUs and Stock Options

Jul 13, 2019

Fosun

Fosun Confirms It’s In Talks to Pay USD941 Million for Thomas Cook

Jul 13, 2019

Gilead Sciences

Gilead Sciences Plans Western China Ops Center in Chengdu

Jul 12, 2019

Scripps Research

Scripps Research Snags $129 Million for HIV Vaccine Investigation

Jul 12, 2019

Beleave Inc

Beleave Commences Sales of Cannabis Oils for the Canadian Adult Use Market

Jul 12, 2019

SinoMab

SinoMab Bioscience, a Hong Kong Biotech, to IPO on Hong Kong Exchange

Jul 11, 2019